{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Aidi injection", "H22 hepatocellular carcinoma", "cell metabolomics", "doxorubicin", "synergistic effect"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35848595", "DateCompleted": {"Year": "2022", "Month": "09", "Day": "13"}, "DateRevised": {"Year": "2022", "Month": "09", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "08", "Day": "08"}], "Language": ["eng"], "ELocationID": ["10.1002/bmc.5451"], "Journal": {"ISSN": "1099-0801", "JournalIssue": {"Volume": "36", "Issue": "10", "PubDate": {"Year": "2022", "Month": "Oct"}}, "Title": "Biomedical chromatography : BMC", "ISOAbbreviation": "Biomed Chromatogr"}, "ArticleTitle": "Cell metabolomics study on synergistic anti-hepatocellular carcinoma effect of Aidi injection combined with doxorubicin.", "Pagination": {"StartPage": "e5451", "MedlinePgn": "e5451"}, "Abstract": {"AbstractText": ["Hepatocellular carcinoma (HCC) is the sixth most common cancer worldwide and the second most common cause of cancer deaths. This study aimed to explore the inhibitory effect and mechanism of Aidi injection (ADI) combined with doxorubicin (DOX) in HCC treatment. The drug concentrations in the combined therapy was determined by investigating the effect of various concentrations of ADI and DOX on the viability of H22 cells. The combination index was also calculated. A metabolomic strategy based on a ultrahigh-performance liquid chromatography tandem mass spectrometry (UHPLC-MS/MS) platform was established to analyze the metabolites. As a result, the combination index values were less than 1, indicating that the combination of ADI and DOX exerted a synergistic effect on HCC treatment. The combination of 40\u2030 ADI and 1\u2009\u03bcmol/l DOX had the strongest inhibitory effect and was used for subsequent metabolomic analysis. A total of 19 metabolic markers were obtained in metabolomic analysis, including amino acids (l-glutamic acid, l-arginine and l-tyrosine), organic acids (succinic acid and citric acid), adenosine and hypoxanthine. Compared with the treatment using DOX or ADI alone, the combined therapy further regulated the levels of metabolic markers in HCC, which may be the reason for the synergistic effect. Seven metabolic pathways were significantly enriched, including phenylalanine, tyrosine and tryptophan biosynthesis, d-glutamine and d-glutamate metabolism, alanine, aspartate and glutamate metabolism, phenylalanine metabolism, arginine biosynthesis, the tricarboxylic acid cycle and purine metabolism. These findings demonstrated that ADI combined with DOX can effectively inhibit the viability of H22 cells, which may exert a synergistic antitumor effect by balancing the metabolism of amino acids and energy-related substances."], "CopyrightInformation": "\u00a9 2022 John Wiley & Sons Ltd."}, "AuthorList": [{"Identifier": ["0000-0002-7396-6215"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "School of Pharmacy, Guizhou Medical University, Yunyan District, Guiyang, China."}], "LastName": "Wang", "ForeName": "Yanli", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Guizhou Medical University, Yunyan District, Guiyang, China."}], "LastName": "Zhu", "ForeName": "Xiaoqing", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Guizhou Medical University, Yunyan District, Guiyang, China."}], "LastName": "Wang", "ForeName": "Kailiang", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Guizhou Medical University, Yunyan District, Guiyang, China."}], "LastName": "Cai", "ForeName": "Ying", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang, China."}], "LastName": "Liu", "ForeName": "Chunhua", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang, China."}], "LastName": "Pan", "ForeName": "Jie", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang, China."}], "LastName": "Sun", "ForeName": "Jia", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang, China."}], "LastName": "Liu", "ForeName": "Ting", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang, China."}], "LastName": "Huang", "ForeName": "Yong", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "School of Pharmacy, Guizhou Medical University, Yunyan District, Guiyang, China."}], "LastName": "Li", "ForeName": "Yongjun", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang, China."}], "LastName": "Lu", "ForeName": "Yuan", "Initials": "Y"}], "GrantList": [{"GrantID": "8186071", "Agency": "National Natural Science Foundation of China", "Country": ""}, {"GrantID": "81860718", "Agency": "National Natural Science Foundation of China", "Country": ""}, {"GrantID": "[2018]4006", "Agency": "The Central Guidance for Local Science and Technology Projects", "Country": ""}, {"GrantID": "KY[2021]033", "Agency": "The Guizhou Education Department", "Country": ""}, {"GrantID": "[2021]171", "Agency": "The Project of Guizhou Provincial Department of Education", "Country": ""}, {"GrantID": "gzwkj2021-450", "Agency": "The Project of Guizhou Provincial Health Commission", "Country": ""}, {"GrantID": "[2021]5619", "Agency": "The Provinvial Program on Scientific Research Projects of The Science and Technology Department of Guizhou Province", "Country": ""}, {"GrantID": "[2021]421", "Agency": "The Science and Technology Department of Guizhou Province", "Country": ""}, {"GrantID": "GCC[2022]031-1", "Agency": "The Science and Technology Department of Guizhou Province", "Country": ""}, {"GrantID": "[2016]5613\\5677", "Agency": "The Team Project of Guizhou Provincial Science and Technology Department", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Biomed Chromatogr", "NlmUniqueID": "8610241", "ISSNLinking": "0269-3879"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Amino Acids"}, {"RegistryNumber": "47E5O17Y3R", "NameOfSubstance": "Phenylalanine"}, {"RegistryNumber": "80168379AG", "NameOfSubstance": "Doxorubicin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Amino Acids"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Carcinoma, Hepatocellular"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Doxorubicin"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Liver Neoplasms"}, {"QualifierName": ["methods"], "DescriptorName": "Metabolomics"}, {"QualifierName": [], "DescriptorName": "Phenylalanine"}, {"QualifierName": ["methods"], "DescriptorName": "Tandem Mass Spectrometry"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Artati, A., Prehn, C., & Adamski, J. (2019). LC-MS/MS-based metabolomics for cell cultures. Methods in Molecular Biology, 1994, 119-130. https://doi.org/10.1007/978-1-4939-9477-9_10"}, {"Citation": "Brosnan, M. E., & Brosnan, J. T. (2009). Hepatic glutamate metabolism: A tale of 2 hepatocytes. The American Journal of Clinical Nutrition, 90(3), 857S-861S. https://doi.org/10.3945/ajcn.2009.27462Z"}, {"Citation": "Cai, Z., Li, C. F., Han, F., Liu, C., Zhang, A., Hsu, C. C., Peng, D., Zhang, X., Jin, G., Rezaeian, A. H., Wang, G., Zhang, W., Pan, B. S., Wang, C. Y., Wang, Y. H., Wu, S. Y., Yang, S. C., Hsu, F. C., D\u2019Agostino, R. B. Jr., \u2026 Lin, H. K. (2020). Phosphorylation of PDHA by AMPK drives TCA cycle to promote Cancer metastasis. Molecular Cell, 80(2), 263-278.e7. https://doi.org/10.1016/j.molcel.2020.09.018"}, {"Citation": "Cao, B., Aa, J., Wang, G., Wu, X., Liu, L., Li, M., Shi, J., Wang, X., Zhao, C., Zheng, T., Guo, S., & Duan, J. (2011). GC-TOFMS analysis of metabolites in adherent MDCK cells and a novel strategy for identifying intracellular metabolic markers for use as cell amount indicators in data normalization. Analytical and Bioanalytical Chemistry, 400(9), 2983-2993. https://doi.org/10.1007/s00216-011-4981-8"}, {"Citation": "Chakravarthi, B., Rodriguez Pena, M. D. C., Agarwal, S., Chandrashekar, D. S., Hodigere Balasubramanya, S. A., Jabboure, F. J., Matoso, A., Bivalacqua, T. J., Rezaei, K., Chaux, A., Grizzle, W. E., Sonpavde, G., Gordetsky, J., Netto, G. J., & Varambally, S. (2018). A role for De novo purine metabolic enzyme PAICS in bladder cancer progression. Neoplasia, 20(9), 894-904. https://doi.org/10.1016/j.neo.2018.07.006"}, {"Citation": "Chen, T., Yang, P., & Jia, Y. (2021). Molecular mechanisms of astragalosideIV in cancer therapy (review). International Journal of Molecular Medicine, 47(3), 13. https://doi.org/10.3892/ijmm.2021.4846"}, {"Citation": "Chen, X., Cao, Z., Zhang, Y., Li, J., Wang, S., Du, J., & Liao, L. (2017). Fuzheng Qingjie granules inhibit growth of hepatoma cells via inducing mitochondria-mediated apoptosis and enhancing immune function. Integrative Cancer Therapies, 16(3), 329-338. https://doi.org/10.1177/1534735416654761"}, {"Citation": "Chen, Z., Xie, H., Hu, M., Huang, T., Hu, Y., Sang, N., & Zhao, Y. (2020). Recent progress in treatment of hepatocellular carcinoma. American Journal of Cancer Research, 10(9), 2993-3036."}, {"Citation": "Chou, T. C. (2010). Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Research, 70(2), 440-446. https://doi.org/10.1158/0008-5472.CAN-09-1947"}, {"Citation": "Chow, A. K., Yau, S. W., & Ng, L. (2020). Novel molecular targets in hepatocellular carcinoma. World Journal of Clinical Oncology, 11(8), 589-605. https://doi.org/10.5306/wjco.v11.i8.589"}, {"Citation": "Chrysanthopoulos, P. K., Goudar, C. T., & Klapa, M. I. (2010). Metabolomics for high-resolution monitoring of the cellular physiological state in cell culture engineering. Metabolic Engineering, 12(3), 212-222. https://doi.org/10.1016/j.ymben.2009.11.001"}, {"Citation": "Ciccarone, F., Vegliante, R., Di Leo, L., & Ciriolo, M. R. (2017). The TCA cycle as a bridge between oncometabolism and DNA transactions in cancer. Seminars in Cancer Biology, 47, 50-56. https://doi.org/10.1016/j.semcancer.2017.06.008"}, {"Citation": "Dai, Z. J., Wang, X. J., Li, Z. F., Ji, Z. Z., Ren, H. T., Tang, W., Liu, X. X., Kang, H. F., Guan, H. T., & Song, L. Q. (2008). Scutellaria barbate extract induces apoptosis of hepatoma H22 cells via the mitochondrial pathway involving caspase-3. World Journal of Gastroenterology, 14(48), 7321-7328. https://doi.org/10.3748/wjg.14.7321"}, {"Citation": "Denkert, C., Budczies, J., Kind, T., Weichert, W., Tablack, P., Sehouli, J., Niesporek, S., K\u00f6nsgen, D., Dietel, M., & Fiehn, O. (2006). Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors. Cancer Research, 66(22), 10795-10804. https://doi.org/10.1158/0008-5472.CAN-06-0755"}, {"Citation": "Dettmer, K., Aronov, P. A., & Hammock, B. D. (2007). Mass spectrometry-based metabolomics. Mass Spectrometry Reviews, 26(1), 51-78. https://doi.org/10.1002/mas.20108"}, {"Citation": "Dietmair, S., Timmins, N. E., Gray, P. P., Nielsen, L. K., & Kromer, J. O. (2010). Towards quantitative metabolomics of mammalian cells: Development of a metabolite extraction protocol. Analytical Biochemistry, 404(2), 155-164. https://doi.org/10.1016/j.ab.2010.04.031"}, {"Citation": "Fan, T., Rong, Z., Dong, J., Li, J., Wang, K., Wang, X., Li, H., Chen, J., Wang, F., Wang, J., & Wang, A. (2017). Metabolomic and transcriptomic profiling of hepatocellular carcinomas in Hras12V transgenic mice. Cancer Medicine, 6(10), 2370-2384. https://doi.org/10.1002/cam4.1177"}, {"Citation": "Faraji, A., Dehghan Manshadi, H. R., Mobaraki, M., Zare, M., & Houshmand, M. (2016). Association of ABCB1 and SLC22A16 gene polymorphisms with incidence of doxorubicin-induced febrile neutropenia: A survey of Iranian breast cancer patients. PLoS ONE, 11(12), e0168519. https://doi.org/10.1371/journal.pone.0168519"}, {"Citation": "Ferrarini, A., di Poto, C., He, S., Tu, C., Varghese, R. S., Kara Balla, A., Jayatilake, M., Li, Z., Ghaffari, K., Fan, Z., Sherif, Z. A., Kumar, D., Kroemer, A., Tadesse, M. G., & Ressom, H. W. (2019). Metabolomic analysis of liver tissues for characterization of hepatocellular carcinoma. Journal of Proteome Research, 18(8), 3067-3076. https://doi.org/10.1021/acs.jproteome.9b00185"}, {"Citation": "Fukuda, H., Ebara, M., Okuyama, M., Sugiura, N., Yoshikawa, M., Saisho, H., Shimizu, R., Motoji, N., Shigematsu, A., & Watayo, T. (2002). Increased metabolizing activities of the tricarboxylic acid cycle and decreased drug metabolism in hepatocellular carcinoma. Carcinogenesis, 23(12), 2019-2023. https://doi.org/10.1093/carcin/23.12.2019"}, {"Citation": "Garcia-Canaveras, J. C., Lopez, S., Castell, J. V., Donato, M. T., & Lahoz, A. (2016). Extending metabolome coverage for untargeted metabolite profiling of adherent cultured hepatic cells. Analytical and Bioanalytical Chemistry, 408(4), 1217-1230. https://doi.org/10.1007/s00216-015-9227-8"}, {"Citation": "Gong, Z. G., Zhao, W., Zhang, J., Wu, X., Hu, J., Yin, G. C., & Xu, Y. J. (2017). Metabolomics and eicosanoid analysis identified serum biomarkers for distinguishing hepatocellular carcinoma from hepatitis B virus-related cirrhosis. Oncotarget, 8(38), 63890-63900. https://doi.org/10.18632/oncotarget.19173"}, {"Citation": "Guo, L., Sun, X., Yan, A. P., Liu, Y. X., Xiao, S. M., Wan, Y. Q., & University, N. (2015). Simultaneous determination of five potential cancer biomarkers in mouse urine by high performance liquid chromatography-tandem mass spectrometry. Journal of Analytical Science, 31(05), 611-615. https://doi.org/10.13526/j.issn.1006-6144.2015.05.004"}, {"Citation": "Guvenc Paltun, B., Kaski, S., & Mamitsuka, H. (2021). Machine learning approaches for drug combination therapies. Briefings in Bioinformatics, 22(6), bbab293. https://doi.org/10.1093/bib/bbab293"}, {"Citation": "Hayton, S., Maker, G. L., Mullaney, I., & Trengove, R. D. (2017). Experimental design and reporting standards for metabolomics studies of mammalian cell lines. Cellular and Molecular Life Sciences, 74(24), 4421-4441. https://doi.org/10.1007/s00018-017-2582-1"}, {"Citation": "Hou, J., Xue, J., Zhao, X., Wang, Z., Li, W., Li, X., & Zheng, Y. (2018). Octyl ester of ginsenoside compound K as novel anti-hepatoma compound: Synthesis and evaluation on murine H22 cells in vitro and in vivo. Chemical Biology & Drug Design, 91(4), 951-956. https://doi.org/10.1111/cbdd.13153"}, {"Citation": "Huang, L., Zhao, C., & Feng, X. (2020). Exploration of nonclinical pharmacodynamics evaluation system of Alzheimer's disease. Acta Pharmaceutica Sinica, 55(5), 789-805. https://doi.org/10.16438/j.0513-4870.2019-0899"}, {"Citation": "Jang, C., Chen, L., & Rabinowitz, J. D. (2018). Metabolomics and isotope tracing. Cell, 173(4), 822-837. https://doi.org/10.1016/j.cell.2018.03.055"}, {"Citation": "Kim, D. W., Talati, C., & Kim, R. (2017). Hepatocellular carcinoma (HCC): Beyond sorafenib-chemotherapy. The Journal of Gastrointestinal Oncology, 8(2), 256-265. https://doi.org/10.21037/jgo.2016.09.07"}, {"Citation": "Korinek, M., Sistek, V., Mladkova, J., Mikes, P., Jiracek, J., & Selicharova, I. (2013). Quantification of homocysteine-related metabolites and the role of betaine-homocysteine S-methyltransferase in HepG2 cells. Biomedical Chromatography, 27(1), 111-121. https://doi.org/10.1002/bmc.2755"}, {"Citation": "Kuo, M. T., Savaraj, N., & Feun, L. G. (2010). Targeted cellular metabolism for cancer chemotherapy with recombinant arginine-degrading enzymes. Oncotarget, 1(4), 246-251. https://doi.org/10.18632/oncotarget.135"}, {"Citation": "Le, A., Lane, A. N., Hamaker, M., Bose, S., Gouw, A., Barbi, J., Tsukamoto, T., Rojas, C. J., Slusher, B. S., Zhang, H., Zimmerman, L. J., Liebler, D. C., Slebos, R. J. C., Lorkiewicz, P. K., Higashi, R. M., Fan, T. W. M., & Dang, C. V. (2012). Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. Cell Metabolism, 15(1), 110-121. https://doi.org/10.1016/j.cmet.2011.12.009"}, {"Citation": "Leon, Z., Garcia-Canaveras, J. C., Donato, M. T., & Lahoz, A. (2013). Mammalian cell metabolomics: Experimental design and sample preparation. Electrophoresis, 34(19), 2762-2775. https://doi.org/10.1002/elps.201200605"}, {"Citation": "Li, W., Li, G., She, W., Hu, X., & Wu, X. (2019). Targeted antitumor activity of Ginsenoside (Rg1) in paclitaxel-resistant human nasopharyngeal cancer cells are mediated through activation of autophagic cell death, cell apoptosis, endogenous ROS production, S phase cell cycle arrest and inhibition of m-TOR/PI3K/AKT signalling pathway. Journal of BUON, 24(5), 2056-2061."}, {"Citation": "Li, W. W., Yang, Y., Wang, S. C., Xie, T., & Shan, J. J. (2017). Research Progress of cellular metabolomics. Journal of Nanjing University of Traditional Chinese Medicine, 33(2), 187-192. https://doi.org/10.14148/j.issn.1672-0482.2017.0187"}, {"Citation": "Li, X., Xiao, C., & Qu, K. (2021). Aidi injection, a traditional Chinese biomedical preparation for gynecologic tumors: A systematic review and PRISMA-compliant meta-analysis. Bioscience Reports, 41(3), BSR20204457. https://doi.org/10.1042/BSR20204457"}, {"Citation": "Li, X. J., Bai, Y. F., Cui, Z., Gao, R., Bao, L. T., & Li, R. S. (2012). Research Progress of laboratory animal models of liver cancer. Chinese Journal of Comparative Medicine, 22(4), 73-77."}, {"Citation": "Liu, C., Knudsen, G. M., Pedley, A. M., He, J., Johnson, J. L., Yaron, T. M., Cantley, L. C., & Benkovic, S. J. (2019). Mapping post-translational modifications of de novo purine biosynthetic enzymes: Implications for pathway regulation. Journal of Proteome Research, 18(5), 2078-2087. https://doi.org/10.1021/acs.jproteome.8b00969"}, {"Citation": "Lu, Y., Pan, J., Yang, S. T., Qiong, W. U., Liu, C. H., Yong-Jun, L. I., & Liu, T. (2018). Effect of Aidi injection on glutathione-S-transferase of diethylnitrosamine-induced hepatocellular carcinoma model rats. Chinese Pharmacological Bulletin, 34(08), 1170-1174."}, {"Citation": "Lu, Y., Pan, J., Zhu, X., Zhang, S., Liu, C., Sun, J., Li, Y., Chen, S., Huang, J., Cao, C., Wang, Y., Li, Y., & Liu, T. (2021). Pharmacokinetic herb-drug interactions between Aidi injection and doxorubicin in rats with diethylnitrosamine-induced hepatocellular carcinoma. BMC Pharmacology and Toxicology, 22(1), 48, 48. https://doi.org/10.1186/s40360-021-00515-9"}, {"Citation": "Lu, Y., Wang, Y., He, Y., Pan, J., Jin, Y., Zheng, L., Huang, Y., Li, Y., & Liu, W. (2022). Aidi injection altered the activity of CYP2D4, CYP1A2, CYP2C19, CYP3A2, CYP2E1 and CYP2C11 in normal and diethylnitrosamine-induced hepatocellular carcinoma in rats. Journal of Ethnopharmacology, 286, 114930. https://doi.org/10.1016/j.jep.2021.114930"}, {"Citation": "Lukey, M. J., Katt, W. P., & Cerione, R. A. (2017). Targeting amino acid metabolism for cancer therapy. Drug Discovery Today, 22(5), 796-804. https://doi.org/10.1016/j.drudis.2016.12.003"}, {"Citation": "Lv, H., Zhen, C., Liu, J., Yang, P., Hu, L., & Shang, P. (2019). Unraveling the potential role of glutathione in multiple forms of cell death in cancer therapy. Oxidative Medicine and Cellular Longevity, 2019, 3150145. https://doi.org/10.1155/2019/3150145"}, {"Citation": "Ma, J. J., & Liu, H. P. (2017). Efficacy of Aidi injection () on overexpression of P-glycoprotein induced by vinorelbine and cisplatin regimen in patients with non-small cell lung cancer. Chinese Journal of Integrative Medicine, 23(7), 504-509. https://doi.org/10.1007/s11655-016-2511-4"}, {"Citation": "Morris, S. M. Jr. (2007). Arginine metabolism: Boundaries of our knowledge. The Journal of Nutrition, 137(6 Suppl 2), 1602S-1609S. https://doi.org/10.1093/jn/137.6.1602S"}, {"Citation": "Neurauter, G., Grahmann, A. V., Klieber, M., Zeimet, A., Ledochowski, M., Sperner-Unterweger, B., & Fuchs, D. (2008). Serum phenylalanine concentrations in patients with ovarian carcinoma correlate with concentrations of immune activation markers and of isoprostane-8. Cancer Letters, 272(1), 141-147. https://doi.org/10.1016/j.canlet.2008.07.002"}, {"Citation": "Nicholson, J. K., Connelly, J., Lindon, J. C., & Holmes, E. (2002). Metabonomics: A platform for studying drug toxicity and gene function. Nature Reviews. Drug Discovery, 1(2), 153-161. https://doi.org/10.1038/nrd728"}, {"Citation": "Paglia, G., Hrafnsdottir, S., Magnusdottir, M., Fleming, R. M., Thorlacius, S., Palsson, B. O., & Thiele, I. (2012). Monitoring metabolites consumption and secretion in cultured cells using ultra-performance liquid chromatography quadrupole-time of flight mass spectrometry (UPLC-Q-ToF-MS). Analytical and Bioanalytical Chemistry, 402(3), 1183-1198. https://doi.org/10.1007/s00216-011-5556-4"}, {"Citation": "Panopoulos, A. D., Yanes, O., Ruiz, S., Kida, Y. S., Diep, D., Tautenhahn, R., Herrer\u00edas, A., Batchelder, E. M., Plongthongkum, N., Lutz, M., Berggren, W. T., Zhang, K., Evans, R. M., Siuzdak, G., & Belmonte, J. C. I. (2012). The metabolome of induced pluripotent stem cells reveals metabolic changes occurring in somatic cell reprogramming. Cell Research, 22(1), 168-177. https://doi.org/10.1038/cr.2011.177"}, {"Citation": "Pascual, G., Dominguez, D., & Benitah, S. A. (2018). The contributions of cancer cell metabolism to metastasis. Disease Models & Mechanisms, 11(8), dmm032920. https://doi.org/10.1242/dmm.032920"}, {"Citation": "Pedley, A. M., & Benkovic, S. J. (2017). A new view into the regulation of purine metabolism: The Purinosome. Trends in Biochemical Sciences, 42(2), 141-154. https://doi.org/10.1016/j.tibs.2016.09.009"}, {"Citation": "Phillips, M. M., Sheaff, M. T., & Szlosarek, P. W. (2013). Targeting arginine-dependent cancers with arginine-degrading enzymes: Opportunities and challenges. Cancer Research and Treatment, 45(4), 251-262. https://doi.org/10.4143/crt.2013.45.4.251"}, {"Citation": "Piska, K., Koczurkiewicz, P., Bucki, A., Wojcik-Pszczola, K., Kolaczkowski, M., & Pekala, E. (2017). Metabolic carbonyl reduction of anthracyclines - role in cardiotoxicity and cancer resistance. Reducing enzymes as putative targets for novel cardioprotective and chemosensitizing agents. Investigational New Drugs, 35(3), 375-385. https://doi.org/10.1007/s10637-017-0443-2"}, {"Citation": "Raimundo, N., Baysal, B. E., & Shadel, G. S. (2011). Revisiting the TCA cycle: Signaling to tumor formation. Trends in Molecular Medicine, 17(11), 641-649. https://doi.org/10.1016/j.molmed.2011.06.001"}, {"Citation": "Roxburgh, P., & Evans, T. R. (2008). Systemic therapy of hepatocellular carcinoma: Are we making progress? Advances in Therapy, 25(11), 1089-1104. https://doi.org/10.1007/s12325-008-0113-z"}, {"Citation": "Ruiz-Aracama, A., Peijnenburg, A., Kleinjans, J., Jennen, D., van Delft, J., Hellfrisch, C., & Lommen, A. (2011). An untargeted multi-technique metabolomics approach to studying intracellular metabolites of HepG2 cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. BMC Genomics, 12, 251. https://doi.org/10.1186/1471-2164-12-251"}, {"Citation": "Segers, K., Declerck, S., Mangelings, D., Heyden, Y. V., & Eeckhaut, A. V. (2019). Analytical techniques for metabolomic studies: A review. Bioanalysis, 11(24), 2297-2318. https://doi.org/10.4155/bio-2019-0014"}, {"Citation": "Shi, Q., Diao, Y., Jin, F., & Ding, Z. (2018). Antimetastatic effects of Aidi on human esophageal squamous cell carcinoma by inhibiting epithelialmesenchymal transition and angiogenesis. Molecular Medicine Reports, 18(1), 131-138. https://doi.org/10.3892/mmr.2018.8976"}, {"Citation": "Son, J., Lyssiotis, C. A., Ying, H., Wang, X., Hua, S., Ligorio, M., Perera, R. M., Ferrone, C. R., Mullarky, E., Shyh-Chang, N., Kang, Y.\u2019., Fleming, J. B., Bardeesy, N., Asara, J. M., Haigis, M. C., DePinho, R. A., Cantley, L. C., & Kimmelman, A. C. (2013). Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature, 496(7443), 101-105. https://doi.org/10.1038/nature12040"}, {"Citation": "Spitzer, S., Volbracht, K., Lundgaard, I., & Karadottir, R. T. (2016). Glutamate signalling: A multifaceted modulator of oligodendrocyte lineage cells in health and disease. Neuropharmacology, 110(Pt B), 574-585. https://doi.org/10.1016/j.neuropharm.2016.06.014"}, {"Citation": "Steffens, D. C., Wei, J., Krishnan, K. R., Karoly, E. D., Mitchell, M. W., O'Connor, C. M., & Kaddurah-Daouk, R. (2010). Metabolomic differences in heart failure patients with and without major depression. Journal of Geriatric Psychiatry and Neurology, 23(2), 138-146. https://doi.org/10.1177/0891988709358592"}, {"Citation": "Sun, W., Liu, X., & Li, W. (2018). Research advances in metabolic markers for hepatocellular carcinoma. Journal of Clinical Hepatology, 34(06), 1318-1324."}, {"Citation": "Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71(3), 209-249. https://doi.org/10.3322/caac.21660"}, {"Citation": "Szefel, J., Danielak, A., & Kruszewski, W. J. (2019). Metabolic pathways of l-arginine and therapeutic consequences in tumors. Advances in Medical Sciences, 64(1), 104-110. https://doi.org/10.1016/j.advms.2018.08.018"}, {"Citation": "Taylor, J., King, R. D., Altmann, T., & Fiehn, O. (2002). Application of metabolomics to plant genotype discrimination using statistics and machine learning. Bioinformatics, 18(Suppl 2), S241-S248. https://doi.org/10.1093/bioinformatics/18.suppl_2.s241"}, {"Citation": "Todisco, S., Convertini, P., Iacobazzi, V., & Infantino, V. (2019). TCA cycle rewiring as emerging metabolic signature of hepatocellular carcinoma. Cancers (Basel), 12(1), 68. https://doi.org/10.3390/cancers12010068"}, {"Citation": "Tsun, Z. Y., & Possemato, R. (2015). Amino acid management in cancer. Seminars in Cell & Developmental Biology, 43, 22-32. https://doi.org/10.1016/j.semcdb.2015.08.002"}, {"Citation": "Wagner, S., Scholz, K., Sieber, M., Kellert, M., & Voelkel, W. (2007). Tools in metabonomics: An integrated validation approach for LC-MS metabolic profiling of mercapturic acids in human urine. Analytical Chemistry, 79(7), 2918-2926. https://doi.org/10.1021/ac062153w"}, {"Citation": "Wang, B., Chen, D., Chen, Y., Hu, Z., Cao, M., Xie, Q., Chen, Y., Xu, J., Zheng, S., & Li, L. (2012). Metabonomic profiles discriminate hepatocellular carcinoma from liver cirrhosis by ultraperformance liquid chromatography-mass spectrometry. Journal of Proteome Research, 11(2), 1217-1227. https://doi.org/10.1021/pr2009252"}, {"Citation": "Wang, C. Q., Zheng, X. T., Chen, X. F., Jiang, H., Huang, J., Jiang, Y., Hu, S. S., Huang, X. R., Liu, S. Y., Gong, Q. H., Feng, J. H., Xiao, X., Li, X. F., & Xiao, Z. (2021). The optimal adjuvant strategy of Aidi injection with gemcitabine and cisplatin in advanced non-small cell lung cancer: A meta-analysis of 70 randomized controlled trials. Frontiers in Pharmacology, 12, 582447. https://doi.org/10.3389/fphar.2021.582447"}, {"Citation": "Wang, Y., Fan, X., Qu, H., Gao, X., & Cheng, Y. (2012). Strategies and techniques for multi-component drug design from medicinal herbs and traditional Chinese medicine. Current Topics in Medicinal Chemistry, 12(12), 1356-1362. https://doi.org/10.2174/156802612801319034"}, {"Citation": "Wei, Z., Liu, X., Cheng, C., Yu, W., & Yi, P. (2020). Metabolism of amino acids in cancer. Frontiers in Cell and Development Biology, 8, 603837. https://doi.org/10.3389/fcell.2020.603837"}, {"Citation": "Wiggins, T., Kumar, S., Markar, S. R., Antonowicz, S., & Hanna, G. B. (2015). Tyrosine, phenylalanine, and tryptophan in gastroesophageal malignancy: A systematic review. Cancer Epidemiology, Biomarkers & Prevention, 24(1), 32-38. https://doi.org/10.1158/1055-9965.EPI-14-0980"}, {"Citation": "Wilson, I. D., Plumb, R., Granger, J., Major, H., Williams, R., & Lenz, E. M. (2005). HPLC-MS-based methods for the study of metabonomics. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 817(1), 67-76. https://doi.org/10.1016/j.jchromb.2004.07.045"}, {"Citation": "Wishart, D. S. (2019). Metabolomics for investigating physiological and pathophysiological processes. Physiological Reviews, 99(4), 1819-1875. https://doi.org/10.1152/physrev.00035.2018"}, {"Citation": "Xia, L., Zhang, H., Wang, X., Zhang, X., & Nie, K. (2021). The role of succinic acid metabolism in ovarian cancer. Frontiers in Oncology, 11, 769196. https://doi.org/10.3389/fonc.2021.769196"}, {"Citation": "Xiao, J. F., Zhou, B., & Ressom, H. W. (2012). Metabolite identification and quantitation in LC-MS/MS-based metabolomics. Trends in Analytical Chemistry, 32, 1-14. https://doi.org/10.1016/j.trac.2011.08.009"}, {"Citation": "Xiao, Z., Wang, C., Li, L., Tang, X., Li, N., Li, J., Chen, L., Gong, Q., Tang, F., Feng, J., & Li, X. (2018). Clinical efficacy and safety of Aidi injection plus docetaxel-based chemotherapy in advanced nonsmall cell lung cancer: A meta-analysis of 36 randomized controlled trials. Evidence-Based Complementary and Alternative Medicine, 2018, 7918258. https://doi.org/10.1155/2018/7918258"}, {"Citation": "Xiao, Z., Wang, C., Sun, Y., Li, N., Li, J., Chen, L., Yao, X., Ding, J., & Ma, H. (2016). Can Aidi injection restore cellular immunity and improve clinical efficacy in non-small-cell lung cancer patients treated with platinum-based chemotherapy? A meta-analysis of 17 randomized controlled trials following the PRISMA guidelines. Medicine (Baltimore), 95(44), e5210. https://doi.org/10.1097/MD.0000000000005210"}, {"Citation": "Xie, G., Cui, Z., Peng, K., Zhou, X., Xia, Q., & Xu, D. (2019). Aidi injection, a traditional Chinese medicine injection, could be used as an adjuvant drug to improve quality of life of cancer patients receiving chemotherapy: A propensity score matching analysis. Integrative Cancer Therapies, 18, 1534735418810799. https://doi.org/10.1177/1534735418810799"}, {"Citation": "Xu, W., Hu, B., Cheng, Y., Guo, Y., Yao, W., & Qian, H. (2022). Material basis research for Echinacea purpurea (L.) Moench against hepatocellular carcinoma in a mouse model through integration of metabonomics and molecular docking. Phytomedicine, 98, 153948. https://doi.org/10.1016/j.phymed.2022.153948"}, {"Citation": "Xu, Y., Liang, P. L., Chen, X. L., Gong, M. J., Zhang, L., Qiu, X. H., Zhang, J., Huang, Z. H., & Xu, W. (2021). The impact of Citrus-tea Cofermentation process on chemical composition and contents of Pu-Erh tea: An integrated metabolomics study. Frontiers in Nutrition, 8, 737539. https://doi.org/10.3389/fnut.2021.737539"}, {"Citation": "Yang, J., Zhao, X., Liu, X., Wang, C., Gao, P., Wang, J., Li, L., Gu, J., Yang, S., & Xu, G. (2006). High performance liquid chromatography-mass spectrometry for metabonomics: Potential biomarkers for acute deterioration of liver function in chronic hepatitis B. Journal of Proteome Research, 5(3), 554-561. https://doi.org/10.1021/pr050364w"}, {"Citation": "Yang, J. S., Wang, C. C., Qiu, J. D., Ren, B., & You, L. (2020). Arginine metabolism: A potential target in pancreatic cancer therapy. Chinese Medical Journal, 134(1), 28-37. https://doi.org/10.1097/CM9.0000000000001216"}, {"Citation": "Yang, X., Gao, M., Miao, M., Jiang, C., Zhang, D., Yin, Z., Ni, Y., Chen, J., & Zhang, J. (2021). Combining combretastatin A4 phosphate with ginsenoside Rd synergistically inhibited hepatocellular carcinoma by reducing HIF-1alpha via PI3K/AKT/mTOR signalling pathway. The Journal of Pharmacy and Pharmacology, 73(2), 263-271. https://doi.org/10.1093/jpp/rgaa006"}, {"Citation": "Yang, Z., Zhang, Q., Yu, L., Zhu, J., Cao, Y., & Gao, X. (2021). The signaling pathways and targets of traditional Chinese medicine and natural medicine in triple-negative breast cancer. Journal of Ethnopharmacology, 264, 113249. https://doi.org/10.1016/j.jep.2020.113249"}, {"Citation": "Yin, J., Ren, W., Huang, X., Deng, J., Li, T., & Yin, Y. (2018). Potential mechanisms connecting purine metabolism and cancer therapy. Frontiers in Immunology, 9, 1697. https://doi.org/10.3389/fimmu.2018.01697"}, {"Citation": "Zhang, A., Sun, H., Xu, H., Qiu, S., & Wang, X. (2013). Cell metabolomics. Omics, 17(10), 495-501. https://doi.org/10.1089/omi.2012.0090"}, {"Citation": "Zhang, E., Shi, H., Yang, L., Wu, X., & Wang, Z. (2017). Ginsenoside Rd regulates the Akt/mTOR/p70S6K signaling cascade and suppresses angiogenesis and breast tumor growth. Oncology Reports, 38(1), 359-367. https://doi.org/10.3892/or.2017.5652"}, {"Citation": "Zhang, T., Zhang, L., Payne, P. R. O., & Li, F. (2021). Synergistic drug combination prediction by integrating multiomics data in deep learning models. Methods in Molecular Biology, 2194, 223-238. https://doi.org/10.1007/978-1-0716-0849-4_12"}, {"Citation": "Zhao, M., Mao, Y., Xu, C., Yao, P., & Jiang, P. (2019). Metabolic remodeling in cancer. Chinese Journal of Cell Biology, 41(07), 1236-1251."}, {"Citation": "Zhou, H., Xu, J., Wang, S., & Peng, J. (2018). Role of cantharidin in the activation of IKKalpha/IkappaBalpha/NFkappaB pathway by inhibiting PP2A activity in cholangiocarcinoma cell lines. Molecular Medicine Reports, 17(6), 7672-7682. https://doi.org/10.3892/mmr.2018.8860"}], "ReferenceList": [], "Title": "REFERENCES"}], "History": [{"Year": "2022", "Month": "7", "Day": "11"}, {"Year": "2022", "Month": "4", "Day": "6"}, {"Year": "2022", "Month": "7", "Day": "12"}, {"Year": "2022", "Month": "7", "Day": "19", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "9", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "7", "Day": "18", "Hour": "7", "Minute": "12"}], "PublicationStatus": "ppublish", "ArticleIdList": ["35848595", "10.1002/bmc.5451"]}}], "PubmedBookArticle": []}